Showing an Association Between RECIST Changes and Survival in Men with Castrate Resistant Prostate Cancer Receiving Chemotherapy

The Response Evaluation Criteria In Solid Tumors (RECIST) was first published in 2000 and then updated in 2009. RECIST is a set of published rules that attempt to define when cancer tumors, including prostate cancer tumors, improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment. This criteria has become very important as the majority [...]

An NCI Clinical Trail After Chemotherapy Has Failed

What do advanced prostate cancer survivors do once we fail chemotherapy? At this time there are no FDA approved next steps other than to take some time off and pray that restarting chemotherapy will again help us. To put in another way, we wait to die. There is a huge need to find additional strategies [...]

By |2020-02-04T10:39:41-05:00January 8th, 2009|Advanced Prostate Cancer,